Exploratory Study of "Natural Killer" Inflammatory Lymphocytes in Waste Per-operating of Tonsillectomy

The aim of this study is to describe the frequency of the presence of cells Natural Killer (NK) expressing CD86 and HLA - DR in tonsils

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tonsillectomy

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient with programmed tonsillectomy as part of the care

Exclusion criteria

patient opposition to use its waste of per-operating tonsillectomy for research purposes
patient with immunosuppressive and/or corticoid treatment (> 1 mg/kg)

Treatment and study plan

Primary outcomes

presence of lymphocytes NK expressing CD86 and HLA - DR

Time frame: inclusion

by immunostaining and detection by flow cytometry

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Registry information

Acronym: LINK

Important dates

Study start: 2014
Primary completion: 2014
Study completion: 2014
First posted: Oct 17, 2017
Registry last updated: Oct 17, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed